Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01282008 · ClinicalTrials.gov registry record
Message Testing for Tobacco-Related Corrective Statements
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 627
- Enrollment target
NCT01282008: Completed study, sponsored by National Cancer Institute (NCI).
NCT01282008 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 627 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01282008 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 627 participants
- Enrollment target
Study Summary
BACKGROUND: This document outlines the study design and procedures to be used to evaluate a series of corrective statements to augment consumer knowledge and beliefs about smoking as related to past actions of tobacco companies. The statements were ordered by a U.S. Federal Court in U.S. v. Philip Morris USA, Inc., and are intended to target potential misperceptions resultant of past marketing and promotion practices undertaken by the tobacco industry. OBJECTIVES: The U.S. Department of Justice has asked NCI to take the lead on developing and testing corrective statements with adult and youth audiences to ensure both message comprehension and avoidance of unintended consequences of message exposure, such as boomerang effects, smoking triggers, or knowledge gaps. The court has identified five areas that the statements shall address: 1. The adverse health effects of smoking; 2. The addictiveness of smoking and nicotine; 3. The lack of any significant health benefit from smoking low tar, light, ultra light, mild, and natural cigarettes; 4. The tobacco industry s manipulation of cigarette design and composition to ensure optimum nicotine delivery; 5. The adverse health effects of secondhand smoke. ELIGIBILITY: Message testing will be undertaken with the following audiences: * Current smokers (with an oversample of low socioeconomic status individuals) * General population nonsmokers and former smokers (with an oversample of low socioeconomic status individuals) * Spanish-speaking Hispanics * Youth age 14-17 DESIGN: Both qualitative and quantitative methods (focus groups and post-test comparison group Web-enabled surveys) will be used to develop and test a range of corrective statements in the five areas outlined by the court. * Focus group participants: 48-64 * Survey participants: 2500
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 627 participants |
| Start Date | 2011-01-21 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01282008
The ClinicalTrials.gov registry entry for NCT01282008 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 627 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01282008 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01282008 about?
NCT01282008 is a clinical study titled "Message Testing for Tobacco-Related Corrective Statements". BACKGROUND: This document outlines the study design and procedures to be used to evaluate a series of corrective statements to augment consumer knowledge and beliefs about smoking as related to past actions of tobacco companies. The statements were ordered by a U.S. Federal Court in U.S. v. Philip ...
What is the current status of trial NCT01282008?
This trial is currently completed. The enrollment target is 627 participants. The study started on 2011-01-21.
Who is sponsoring clinical trial NCT01282008?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.